985 related articles for article (PubMed ID: 26276717)
1. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
2. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomics for understanding oncology: recent advances and future prospects.
Subbannayya Y; Pinto SM; Gowda H; Prasad TS
Expert Rev Proteomics; 2016; 13(3):297-308. PubMed ID: 26697917
[TBL] [Abstract][Full Text] [Related]
4. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer.
Bottoni P; Giardina B; Pontoglio A; Scarà S; Scatena R
Adv Exp Med Biol; 2012; 942():423-40. PubMed ID: 22399434
[TBL] [Abstract][Full Text] [Related]
8. Cancer proteomics.
Tan HT; Lee YH; Chung MC
Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
[TBL] [Abstract][Full Text] [Related]
9. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
[TBL] [Abstract][Full Text] [Related]
10. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.
Shukla HD
Proteomes; 2017 Oct; 5(4):. PubMed ID: 29068423
[TBL] [Abstract][Full Text] [Related]
12. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
14. Proteomics in cancer research: Are we ready for clinical practice?
Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in clinical oncoproteomics.
Jain KK
J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
[TBL] [Abstract][Full Text] [Related]
16. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
17. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1: a novel prognostic biomarker of radioresistance in cancer.
Mahmood J; Zaveri SR; Murti SC; Alexander AA; Connors CQ; Shukla HD; Vujaskovic Z
Int J Radiat Biol; 2016 Dec; 92(12):747-753. PubMed ID: 27623870
[TBL] [Abstract][Full Text] [Related]
19. Proteome research in urothelial carcinoma.
Kageyama S; Isono T; Iwaki H; Hanada E; Tomita K; Yoshida T; Yoshiki T; Kawauchi A
Int J Urol; 2015 Jul; 22(7):621-8. PubMed ID: 25944546
[TBL] [Abstract][Full Text] [Related]
20. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
